{
    "clinical_study": {
        "@rank": "141301", 
        "arm_group": [
            {
                "arm_group_label": "Hi-maize resistant starch", 
                "arm_group_type": "Experimental", 
                "description": "13.5 g/day"
            }, 
            {
                "arm_group_label": "Maltodextrin", 
                "arm_group_type": "Placebo Comparator", 
                "description": "13.5 g/day"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to evaluate the effects of resistant starch supplementation\n      on antioxidant status and insulin resistance in overweight and obese adults."
        }, 
        "brief_title": "Resistant Starch, Antioxidant Status and Insulin Resistance", 
        "condition": [
            "Overweight", 
            "Obesity"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Insulin Resistance", 
                "Obesity", 
                "Overweight"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Overweight and Obese men and women\n\n          -  Age 20-50 years\n\n        Exclusion Criteria:\n\n          -  weight loss or gain (more than10%) over the past 6 months, or weight loss (more than\n             5%) over the past 1 month\n\n          -  pregnancy, lactation or menopause\n\n          -  History of acute disease or clinical evidence of  cancer, acute or chronic\n             inflammatory diseases, cardiovascular disease, renal disease, liver disease, thyroid\n             or endocrine disease\n\n          -  Gastrointestinal disease which ingredients found in the study products has negative\n             effects on that\n\n          -  Use of  glucose lowering, lipid lowering or anti-hypertensive medication\n\n          -  Taking antioxidant, vitamin, and/or mineral supplements\n\n          -  smoking"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "21", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01992783", 
            "org_study_id": "umsu.rec.1392.75"
        }, 
        "intervention": [
            {
                "arm_group_label": "Hi-maize resistant starch", 
                "description": "13.5 g/day", 
                "intervention_name": "Hi-maize resistant starch", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Maltodextrin", 
                "description": "13.5 g/day", 
                "intervention_name": "Maltodextrin", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antioxidants", 
                "Insulin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Resistant Starch", 
            "Antioxidant Status", 
            "Insulin Resistance", 
            "Overweight", 
            "Obesity"
        ], 
        "lastchanged_date": "November 19, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Urmia", 
                    "country": "Iran, Islamic Republic of", 
                    "state": "Azerbaijan-gharbi"
                }
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Resistant Starch Supplementation on Antioxidant Status and Insulin Resistance in Overweight and Obese Adults", 
        "overall_official": {
            "affiliation": "Assistant Professor in Nutrition", 
            "last_name": "Mohammad Alizadeh, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Plasma superoxide dismutase (SOD) Plasma malondialdehyde (MDA)", 
            "measure": "Antioxidant status", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01992783"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Fasting glucose Fasting insulin Insulin resistant (HOMA-IR)", 
            "measure": "Insulin resistance", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "source": "Urmia University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Urmia University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}